Tianjin Tianyao Pharmaceuticals (600488.SH): Formoterol fumarate inhalation solution has obtained a drug registration certificate.

21/01/2025

GMT Eight

Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary Jin Yao Heping (Tianjin) Pharmaceutical Co., Ltd. ("Jin Yao Heping") has received the Drug Registration Certificate for the approval and issuance of formoterol fumarate inhalation solution from the National Medical Products Administration. It is reported that formoterol fumarate inhalation solution is suitable for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), primarily used for chronic bronchitis and emphysema, and can produce long-lasting anti-asthmatic effects. Up to now, Jin Yao Heping has accumulated research and development expenses of approximately 3.97 million yuan for the formoterol fumarate inhalation solution project.

Guizhou Panjiang Refined Coal (600395.SH): The Panjiang Puding 266 MW coal-fired power generation project has been completed and put into operation.

Morgan Stanley: It is expected that the stock price of CGN MINING (01164) will have approximately a 60-70% chance of increasing in the next 15 days.

Contact: contact@gmteight.com

Tianjin Tianyao Pharmaceuticals (600488.SH): Formoterol fumarate inhalation solution has obtained a drug registration certificate.

RECOMMEND

SHANGHAI XNG (03666): Gu Tongshan appointed as executive director.

Huaneng Lancang River Hydropower Inc. (600025.SH) has announced a forecasted increase, with an estimated net profit of 7.848 to 9.087 billion yuan in 2024, representing a year-on-year increase of 2.75% to 18.97%.

Zijin Mining Group (601899.SH) has announced an expected increase in net profit for the year 2024 to be approximately 32 billion yuan, an increase of about 51.5% year-on-year.